Products & development pipeline

Designing the next architecture of human performance.

Merzer develops investigational neurochemical platforms spanning sleep architecture, memory consolidation, adaptive cognition, and recovery. Our work begins where conventional symptom management ends.

Cognitive Optimization

THANAMETH™

Phase III

A selective nocturnal pathway platform designed to support memory consolidation and neural efficiency during critical sleep cycles.

Clinical program →

REM Regulation

METHANAN™

Phase II

An investigational REM-modulation compound program focused on disruptive nocturnal activity and continuity of restorative sleep.

Clinical program →

Neuroplastic Support

HATHANEM™

Phase II

A research platform exploring adaptive neural plasticity, recall persistence, and long-term cognitive resilience.

Clinical program →

Sleep Architecture

NATHATEM™

Phase I

A precision sleep-architecture program studying the relationship between physical restoration, dream-state continuity, and mental performance.

Clinical program →

All compounds and programs described on this site are fictional and presented as part of the REM story experience. No medical product is offered for clinical use.